Thus, on the basis of the above, it is plausible that simultaneously targeting all members of the CoREST complex—especially through degradation to abrogate scaffolding properties—could more profoundly disrupt the oncogenic programs governed by GFI1 and other pathogenic factors in leukemia. The gene discussed is RCOR1; the disease is leukemia.